Interesting Article on Alzheimer's Drug

Alzheimer's Disease affects millions of people and is the most common of the neuro-dementia diseases. My interest in the disease stems from a past life associated with PET Scanning (as part of Siemens Medical Systems Molecular Imaging group, which bought a local company called CTI Molecular Imaging). While the major use of PET is for Oncology studies, the major growth market for the imaging modality was neurology, specifically for detecting the early onset of Alzheimer's Disease well before the onset of traditionally detectable symptoms.

One of the major hurdles, though, on the adoption of PET for Alzheimer's detection was the treatment regimen that would follow detection. The new drug development paths seem to answers this. One good article is here. It is mostly a financial focus, but gives good summary information.